S10.3d Yeast Microbiome in patients with inflammatory bowel disease (IBD)

Abstract S10.3 The mycobiome characterization: future perspectives or just a trend?, September 24, 2022, 10:30 AM - 12:00 PM   Objective The intestinal microbiota plays major roles in host-protective functions and inflammatory bowel diseases (IBDs). Although some data suggest a role of the yeast mic...

Full description

Saved in:
Bibliographic Details
Published in:Medical mycology (Oxford) 2022-09, Vol.60 (Supplement_1)
Main Authors: Vaezi, Afsane, Fakhim, Hamed, Jabbari, Mehrdad, Nasri, Elahe, Azar, Mohammad Reza Hosseini, Diba, Kambiz, Badali, Hamid
Format: Article
Language:English
Subjects:
Oral Presentations
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract S10.3 The mycobiome characterization: future perspectives or just a trend?, September 24, 2022, 10:30 AM - 12:00 PM   Objective The intestinal microbiota plays major roles in host-protective functions and inflammatory bowel diseases (IBDs). Although some data suggest a role of the yeast microbiota in IBD pathogenesis, the available data are rare. The aim of this study was to evaluate the fecal yeast microbiota in patients with IBD. Methods Fungal isolates of the fecal microbiota of 120 patients with IBD and 30 healthy control individuals were determined using conventional and molecular (ITS sequencing and RFLP) methods. Results The mean age of the patients was 37.4 ± 12.2 years (range 15-72 years). Of 120 patients included, 67 had ulcerative colitis (55.8%) and 53 had Crohn's disease (44.2%). Ulcerative colitis was more prevalent in women than Crohn's disease (61.7% vs 50.2%, P 
ISSN:1369-3786
1460-2709
DOI:10.1093/mmy/myac072.S10.3d